Press Releases

You Narrowed By: Business/Product Release

Showing 71-105 of 174

First Prev 1 2 3 4 5 Next Last

2012
April
April 9	Abbott Receives Approval for Next-Generation XIENCE PRIME™ Drug Eluting Stent in Japan
April 4	Abbott to Present Positive Phase 2 Results from Multiple Interferon-Free Studies of Combination Regimens for the Treatment of Hepatitis C

March
March 30	Abbott's PLEX-ID Molecular System and Tests for Broad Microbial Identification Obtain CE Marking
March 21	Abbott Selects AbbVie as New Name for Future Research-Based Pharmaceutical Company
March 20	Abbott Reinforces Global Vascular Leadership with New Data on Innovative Technologies at ACC 2012
March 15	Abbott Announces Patient Enrollment in Two Phase 3 Studies of HUMIRA® (adalimumab) for Moderate to Severe Hidradenitis Suppurativa - (Europe)
March 15	Abbott Announces Patient Enrollment in Two Phase 3 Studies of HUMIRA® (adalimumab) for Moderate to Severe Hidradenitis Suppurativa - (U.S.)
March 12	New Publication Presents Comparative Efficacy Data for Abbott's Zemplar® (paricalcitol) in Treating Secondary Hyperparathyroidism in Hemodialysis Patients
March 8	Abbott's New FreeStyle InsuLinx Blood Glucose Monitoring System Receives FDA Clearance
March 7	Abbott's Absolute Pro® Vascular Self-Expanding Stent System Receives FDA Approval for Treatment of Iliac Artery Disease
March 6	Abbott and Merck Collaborate to Develop Companion Diagnostic Test for Investigational Cancer Therapy
March 5	Abbott to Collaborate on Rapid Molecular Test to Identify Serious Infections in Bones and Joint
March 2	Abbott's STARLIMS Business Acquires Distribution Partners to Build International Presence
March 1	Abbott to Build Nutrition Manufacturing Facility in Ohio

February
February 29	Abbott and Galapagos Announce Global Collaboration for Novel Oral Therapy, GLPG0634, in Phase II to Treat Autoimmune Diseases
February 23	Abbott Collaborates with Leading U.S. Forensics Center on Human Identification Testing
February 17	Abbott Receives Positive Opinion for HUMIRA® in Ulcerative Colitis from EMA's CHMP
February 13	Study Shows Abbott's Tacrolimus Assay Demonstrates Consistent Organ Transplant Drug Monitoring
February 8	Abbott Creates New Similac SimplySmart™ Baby Bottle with Innovative Features
February 1	Abbott to Present at Leerink Swann 2012 Global Healthcare Conference

January
January 30	DNDi and Abbott Expand Partnership to Boost Innovation for Neglected Tropical Diseases
January 18	Abbott’s STARLIMS LIMS Technology to be Installed in FDA Testing Laboratories
2011
December
December 22	Abbott Initiates Clinical Trial to Study Drug Eluting Bioresorbable Therapy for Treatment of Peripheral Artery Disease
December 8	Abbott Initiates Clinical Trial to Evaluate the Absorb™ Bioresorbable Vascular Scaffold Compared to a Metallic Drug Eluting Stent

November
November 30	Abbott Receives FDA Clearance for New Test to Detect Vitamin D Levels
November 28	Abbott Expands Agreement with GSK to Include Development of a Companion Diagnostic Test for an Additional Investigational Cancer Immunotherapy Antigen
November 21	Abbott Introduces the First FDA-Approved Supplemental Blood Test for Chagas Disease
November 15	Abbott Statement on the Results of the AIM-HIGH Study Presented at AHA 2011
November 14	New Data Reinforce Clinical Performance of Abbott's ABSORB Bioresorbable Vascular Scaffold
November 9	Abbott Receives CE Mark for New Hepatitis Test
November 8	Abbott Reports Five-Year Data for HUMIRA® (Adalimumab) in Ankylosing Spondylitis
November 7	Abbott Presents HUMIRA® (Adalimumab) Phase 3 Study Results for Patients with Active Non-Radiographic Axial Spondyloarthritis
November 6	Abbott Announces New Long-Term Data Evaluating Use of HUMIRA® (Adalimumab) for Patients with Long-Standing Moderate to Severe Rheumatoid Arthritis and for Patients with Early Moderate to Severe RA
November 4	Abbott Announces Winners of "CFChef Challenge" Recipe Contest as Part of Online Nutrition Resource for People Affected by Cystic Fibrosis
November 3	Abbott to Present New Data for Key Vascular Products at TCT 2011

First Prev 1 2 3 4 5 Next Last

Narrow by Year

Narrow to Show

For a different perspective on Abbott News. . .

View Abbott Feature Stories

© 2006, 2013 Abbott Laboratories, Abbott Park, Illinois, USA

Unless otherwise specified, all product names appearing in this Internet site are trademarks owned by or licensed to Abbott Laboratories, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott Laboratories, except to identify the product or services of the company.